Related Experiment Video
Updated: Jan 22, 2026

Zinc-Sponge Battery Electrodes that Suppress Dendrites
Published on: September 29, 2020
Long non-coding RNA LINC00641 suppresses non-small-cell lung cancer by sponging miR-424-5p to upregulate PLSCR4
Abstract:
Non-small cell lung cancer (NSCLC) , as the most prevalent type of lung carcinoma with high severity, is of urgent necessity to be investigated for novel therapeutic strategies. Long non-coding RNAs (lncRNAs) are notable for their participation in cancer regulation, and lncRNA long intergenic non-protein coding RNA 641 (LINC00641) has been found to have an inhibitory influence on bladder cancer, but its role in NSCLC has not yet been studied. In this research, we launched an investigation into the biological functions and the underlying molecular mechanisms of LINC00641 in NSCLC. At first, downregulation of LINC00641 was identified in NSCLC cells. Functionally, LINC00641 suppressed cell proliferation and induced cell apoptosis in NSCLC, indicating that LINC00641 exerted tumor-suppressive role in NSCLC. Through mechanism investigation, we determined that LINC00641 acted as a competing endogenous RNA (ceRNA) in NSCLC by sponging miR-424-5p to upregulate phospholipid scramblase (PLSCR4) expression. Further rescue assays indicated that miR-424-5p and PLSCR4 could reverse LINC00641-mediated cellular processes. Taken together, it is demonstrated in our study that LINC00641 can function as a tumor suppressor in NSCLC via a ceRNA network.
Insights
Long non-coding RNA LINC00641 acts as a tumor suppressor in non-small cell lung cancer (NSCLC). It inhibits NSCLC cell proliferation and promotes apoptosis by sponging miR-424-5p to regulate PLSCR4 expression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Non-small cell lung cancer (NSCLC) is a prevalent and severe malignancy requiring new therapies.
- Long non-coding RNAs (lncRNAs) are implicated in cancer, but the role of LINC00641 in NSCLC is unknown.
- Previous studies suggest LINC00641 inhibits bladder cancer progression.
Purpose of the Study:
- To investigate the function and molecular mechanisms of LINC00641 in NSCLC.
- To determine if LINC00641 acts as a tumor suppressor or oncogene in NSCLC.
- To elucidate the potential ceRNA network involving LINC00641 in NSCLC.
Main Methods:
- Quantitative real-time PCR to assess LINC00641 expression in NSCLC cells.
- In vitro assays to evaluate the effects of LINC00641 on cell proliferation and apoptosis.
- Mechanism studies involving RNA immunoprecipitation and luciferase reporter assays to confirm the ceRNA network.
Main Results:
- LINC00641 was found to be downregulated in NSCLC cells.
- Overexpression of LINC00641 suppressed NSCLC cell proliferation and induced apoptosis.
- LINC00641 functions as a competing endogenous RNA (ceRNA) by sponging miR-424-5p, leading to the upregulation of PLSCR4.
Conclusions:
- LINC00641 acts as a tumor suppressor in NSCLC.
- The LINC00641/miR-424-5p/PLSCR4 axis plays a critical role in NSCLC progression.
- LINC00641 may represent a potential therapeutic target for NSCLC treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
RNA Splicing
RNA Polymerase II Accessory Proteins
Ribosomal RNA Synthesis
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
Nursing Code of Ethics

